.png)
R&A PSYINS Issues “Psychedelic Medicine Year-End Analysis and 2024 Outlook” Report"
Navigating the Opportunities, Challenges and Unique Risks of Providing Breakthrough Treatments. Access the report here...
top of page
R&A PSYINS News, Articles & Events
R&A PSYINS Sponsors reMind Psychedelic Business Conference
Rahn & Associates is pleased to sponsor reMind 2023 Psychedelics Business Forum on November 28-29, 2023 in Las Vegas. As more...
Opportunities & Challenges with Opening a Non-Profit Ketamine Clinic
Non-profits are paving the way for affordable access to ketamine therapies. Here are the essential insurances they require to be successful.
NCIA's RMIC Releases"A Novel Cannabinoid Conundrum - Loopholes, Liability, and Legislation"
This manual will help cannabis businesses navigate the insurance sector with a focus on novel cannabinoids and product liability policies.
R&A PSYINS and Psychedelic Invest Host “Trials and Triumphs of Operating a Ketamine Clinic” Webinar
Listen to experienced operators of ketamine clinics in the U.S. share their journey on starting and administering ketamine-assisted therapy.
bottom of page